About the event
Join us for the first in-person o2h ChaiTime, hosted in collaboration with J.P. Morgan, taking place at J.P. Morgan Private Bank, London, on Thursday, 5 February 2026, from 14:00 onwards.
Following the J.P. Morgan Healthcare Conference in the US, this session brings together a carefully curated group of investors, strategic partners, and industry leaders to discuss where biotech is heading in 2026.
The afternoon will include a keynote on the broader biotech landscape, followed by two panel discussions. The first will look at how the sector is rebounding and where market and investor sentiment is heading. The second will focus on anti-obesity, next-generation therapies, and the next wave of GLP-1 innovation. The session will wrap up with informal networking over drinks.
The London Edition will reflect this evolution. The format is being refined to focus on insight-led panel discussions, bringing together senior investors and experienced operators for an open, non-promotional conversation.
What’s on the agenda: –
14:00–14:15 – Arrivals and networking
14:15–14:20 – Welcome address by JPM
14:20–14:25 – Welcome address by Sunil Shah, CEO – o2h Ventures
14:25–14:45 – Keynote: Macro Perspectives on Global Biotech Capital Markets
14:45–15:15 – Panel I – Industry Rebound, Market Conditions and Investor Sentiment
15:15–15:30. Short break
15:30–16:00 – Panel II – Anti-Obesity, Next-Generation Therapies and GLP-1 Strategies
16:00–16:05 – Closing comments
16:05 onwards – Informal networking, drinks and refreshments
Panelists include:-
Panel I:- Industry Rebound, Market Conditions and Investor Sentiment
Moderator – Sunil Shah, CEO – o2h Ventures
– Andy Richards CBE, Serial Entrepreneur
– Jenny Laird, VP – Search and Evaluation Neuroscience
– Eli Lilly – Sohaib Mir – Partner, LifeArc Ventures
– Ali Jazayeri – Operating Partner, SV Health Investors
Panel II:- Anti-Obesity, Next-Generation Therapies and GLP-1 Strategies
Moderator – Dr Tim Sparey. Executive Chair, Hawkhill Therapeutics
– Sutha Satkunarajah – Vice President of Strategy and Operations, Flagship Pioneering
– Wendy Winchester – Senior Director, External Partnerships, Nxera Pharma
– Dr Raj Singh Chandok – GP Partner and Clinical Leader
– Xavier Jacq – Chief Scientific Officer, MitoRx Therapeutics
Please note:
This is an invitation-only event and capacity is limited. Registrations will initially be placed on a waitlist. If your place is confirmed, you will receive a separate official invitation directly from J.P. Morgan, which is required for final registration and venue access.
